[HTML][HTML] Helicobacter pylori in ancient human remains
The bacterium Helicobacter pylori (H. pylori) infects the stomachs of approximately 50% of
all humans. With its universal occurrence, high infectivity and virulence properties it is …
all humans. With its universal occurrence, high infectivity and virulence properties it is …
[HTML][HTML] miR‑155, miR‑96 and miR‑99a as potential diagnostic and prognostic tools for the clinical management of hepatocellular carcinoma
S Ning, H Liu, B Gao, W Wei, A Yang… - Oncology …, 2019 - spandidos-publications.com
Increasing evidence has demonstrated that circulating microRNAs (miRNAs) can be utilized
as potential biomarkers for the diagnosis of cancer, as well as a prognostic tool for the …
as potential biomarkers for the diagnosis of cancer, as well as a prognostic tool for the …
Identification of platform-independent diagnostic biomarker panel for hepatocellular carcinoma using large-scale transcriptomics data
The high mortality rate of hepatocellular carcinoma (HCC) is primarily due to its late
diagnosis. In the past, numerous attempts have been made to design genetic biomarkers for …
diagnosis. In the past, numerous attempts have been made to design genetic biomarkers for …
Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients
Background The expression of microRNAs (miRNAs) is a promising prognostic and
diagnostic tool in hepatocellular carcinoma (HCC). Here we performed small RNA …
diagnostic tool in hepatocellular carcinoma (HCC). Here we performed small RNA …
Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma
J Li, B Jin, T Wang, W Li, Z Wang, H Zhang… - Cancer …, 2019 - content.iospress.com
BACKGROUND: The identification of high-sensitivity biomarkers for detection of
hepatocellular carcinoma (HCC) from high-risk individuals is essential. OBJECTIVE: The …
hepatocellular carcinoma (HCC) from high-risk individuals is essential. OBJECTIVE: The …
[HTML][HTML] Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles
Y Ding, JL Yan, AN Fang, WF Zhou, L Huang - Oncotarget, 2017 - ncbi.nlm.nih.gov
The diagnostic value and suitability of circulating miRNAs for the detection of hepatocellular
carcinoma have been inconsistent in the literature. A meta-analysis is used to systematically …
carcinoma have been inconsistent in the literature. A meta-analysis is used to systematically …
[HTML][HTML] MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes
BACKGROUND Nonalcoholic steatohepatitis-related cirrhosis is one of the liver
complications in type 2 diabetes mellitus (T2DM) and reported to be a risk factor for …
complications in type 2 diabetes mellitus (T2DM) and reported to be a risk factor for …
Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage
Q Sun, J Li, B Jin, T Wang, J Gu - Clinics and Research in Hepatology and …, 2020 - Elsevier
Background and aims This study aimed to investigate the diagnostic values of serum miR-
331-3p and miR-23b-3p as tumor markers for the diagnosis of hepatocellular carcinoma …
331-3p and miR-23b-3p as tumor markers for the diagnosis of hepatocellular carcinoma …
Identification of miRNA and mRNA expression profiles by PCR microarray in hepatitis B virus‑associated hepatocellular carcinoma
XW Cui, ZL Qian, C Li, SC Cui - Molecular Medicine …, 2018 - spandidos-publications.com
The present study aimed to identify differentially expressed microRNAs (miRNAs) and
mRNAs in hepatitis B virus‑associated hepatocellular carcinoma (HCC). A total of five HCC …
mRNAs in hepatitis B virus‑associated hepatocellular carcinoma (HCC). A total of five HCC …
[HTML][HTML] The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma
R Ashida, Y Okamura, K Ohshima, Y Kakuda… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Abstract Project HOPE (High-tech Omics-based Patient Evaluation) began in 2014 using
integrated gene expression profiling (GEP) of cancer tissues as well as diathesis of each …
integrated gene expression profiling (GEP) of cancer tissues as well as diathesis of each …